Mesoblast Ltd
MEOBF- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesMESO
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MEOBF, Q2 2026
No superinvestor reported holding MEOBF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Mesoblast Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 (view filing) | Apr 4-10 | 9 daysLate | George GregoryDirector, 10% Owner | PPurchase | +7.91M | $1.44 | +$11.4M | +1,915.0%8.32M after | 15 lots |
| Apr 10, 2026 (view filing) | Apr 4-10 | 6 daysLate | George GregoryDirector, 10% Owner | PPurchase | +8.31M | $3.15 | +$26.1M | +45,864.0%8.32M after | 15 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Mesoblast Ltd at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding MEOBF in 13F filings for Q2 2026.